Identification of reliable biomarkers to distinguish pathological angiogenesis from compensatory responses is another critical area
The primary allegation in these lawsuits is that these drugs, which belong to a class called GLP-1 agonists, may cause severe gastrointestinal issues like gastroparesis (stomach paralysis), ileus (intestinal blockage), and other serious health problems
Toxicol Appl Pharmacol 204:238255 Ballatori N, Krance SM, Marchan R, Hammond CL (2009a) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
These agents exhibit partial or full sequence homology with human GLP-1, but incorporate strategic alterationssuch as N-terminal protection or enhanced affinity for plasma proteins like albuminas summarized in Table 4 [8]
Statistical analysis Only participants that completed the required blood draws in the clinical trials were included in this study
The literature is still developing